Stay updated on Cofetuzumab Pelidotin in PTK7+ NSCLC: Efficacy and Safety Clinical Trial

Sign up to get notified when there's something new on the Cofetuzumab Pelidotin in PTK7+ NSCLC: Efficacy and Safety Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cofetuzumab Pelidotin in PTK7+ NSCLC: Efficacy and Safety Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3. This appears to be a general site version update with no visible changes to study content or navigation.
    Difference
    0.0%
    Check dated 2026-03-12T01:24:06.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Revision updated to v3.4.2; the funding-lapse notice and the prior revision notice (v3.4.1) were removed.
    Difference
    0.4%
    Check dated 2026-02-11T11:41:40.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    A site-wide funding notice was added and the site version updated to v3.4.1, replacing the previous revision v3.4.0.
    Difference
    0.4%
    Check dated 2026-02-04T10:17:52.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    No core content changes; minor UI/metadata text updates were made, including Show glossary, Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T06:08:35.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Footer revision tag updated from Revision: v3.3.3 to Revision: v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T03:18:54.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    The Study Locations section was updated: new sites were added across several U.S. states and international locations (e.g., Alabama, Arkansas, California, Colorado, Florida, Missouri, Ohio, Tennessee, Texas, Virginia, Tel Aviv, Chiba, Tokyo, Gyeonggido, Seoul Teugbyeolsi), and several existing sites were removed.
    Difference
    2%
    Check dated 2025-12-23T12:46:40.000Z thumbnail image

Stay in the know with updates to Cofetuzumab Pelidotin in PTK7+ NSCLC: Efficacy and Safety Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cofetuzumab Pelidotin in PTK7+ NSCLC: Efficacy and Safety Clinical Trial page.